Bydureon

Active Ingredient(s): Exenatide
FDA Approved: * January 27, 2012
Pharm Company: * AMYLIN
Category: Diabetes

Exenatide, sold under the brand name Byetta and Bydureon among others, is a medication used to treat diabetes mellitus type 2.[6] It is used together with diet, exercise, and potentially other antidiabetic medication.[6] It is a treatment option after metformin and sulfonylureas.[7] It is given by injection under the skin within an hour before the first and last meal of the day.[6] A once-weekly injection version is also availabl... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bydureon Kit
NDC: 0310-6520
Labeler:
Astrazeneca Pharmaceuticals Lp
Bydureon 2 mg/.65ml Subcutaneous Injection, Suspension, Extended Release
NDC: 0310-6530
Labeler:
Astrazeneca Pharmaceuticals Lp
Bydureon Kit
NDC: 66780-219
Labeler:
Amylin Pharmaceuticals, LLC
Bydureon Kit
NDC: 66780-226
Labeler:
Amylin Pharmaceuticals, LLC

Related Brands

Drugs with the same active ingredients